First Trust Advisors LP Innoviva, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Innoviva, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 234,617 shares of INVA stock, worth $4.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

234,617

Previous 278,056 15.62%

Holding current value

$4.45 Million

Previous $4.56 Million 0.7%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$16.33 - $20.04 $709,358 - $870,517	-43,439 Reduced 15.62%	234,617 $4.53 Million
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $4 Million - $4.56 Million	278,056 New	278,056 $4.56 Million
Q3 2023 Nov 13, 2023	BUY	$12.37 - $13.89 $712,920 - $800,522	57,633 New	57,633 $748,000
Q2 2022 Aug 12, 2022	SELL	$14.32 - $19.88 $525,415 - $729,417	-36,691 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $564,674 - $742,992	36,691 New	36,691 $710,000
Q4 2021 Feb 08, 2022	SELL	$15.91 - $18.72 $5.56 Million - $6.54 Million	-349,317 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $1.21 Million - $1.6 Million	-93,016 Reduced 21.03%	349,317 $5.84 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $4.55 Million - $5.55 Million	397,449 Added 885.5%	442,333 $5.93 Million
Q1 2021 May 14, 2021	BUY	$11.06 - $12.87 $101,199 - $117,760	9,150 Added 25.61%	44,884 $536,000
Q4 2020 Feb 02, 2021	SELL	$9.33 - $12.48 $484,376 - $647,911	-51,916 Reduced 59.23%	35,734 $443,000
Q3 2020 Nov 05, 2020	SELL	$10.33 - $14.49 $123,371 - $173,054	-11,943 Reduced 11.99%	87,650 $916,000
Q2 2020 Jul 22, 2020	BUY	$11.49 - $15.26 $221,963 - $294,792	19,318 Added 24.06%	99,593 $1.39 Million
Q1 2020 May 06, 2020	BUY	$8.11 - $15.23 $429,984 - $807,479	53,019 Added 194.52%	80,275 $944,000
Q4 2019 Feb 03, 2020	SELL	$10.28 - $14.38 $765,654 - $1.07 Million	-74,480 Reduced 73.21%	27,256 $386,000
Q3 2019 Nov 04, 2019	BUY	$10.05 - $14.55 $818,683 - $1.19 Million	81,461 Added 401.78%	101,736 $1.07 Million
Q2 2019 Jul 30, 2019	SELL	$13.1 - $14.95 $2.6 Million - $2.97 Million	-198,762 Reduced 90.74%	20,275 $295,000
Q1 2019 May 09, 2019	BUY	$13.69 - $20.06 $1.27 Million - $1.86 Million	92,637 Added 73.29%	219,037 $3.07 Million
Q4 2018 Feb 07, 2019	BUY	$13.96 - $18.26 $1.15 Million - $1.5 Million	82,335 Added 186.85%	126,400 $2.21 Million
Q3 2018 Oct 25, 2018	SELL	$13.63 - $15.7 $1.94 Million - $2.24 Million	-142,401 Reduced 76.37%	44,065 $672,000
Q2 2018 Aug 02, 2018	BUY	$13.44 - $17.59 $878,492 - $1.15 Million	65,364 Added 53.97%	186,466 $2.57 Million
Q1 2018 Apr 23, 2018	BUY	$13.8 - $16.99 $342,819 - $422,065	24,842 Added 25.81%	121,102 $2.02 Million
Q4 2017 Feb 08, 2018	BUY	$11.73 - $14.75 $239,632 - $301,327	20,429 Added 26.94%	96,260 $1.37 Million
Q3 2017 Oct 24, 2017	BUY	$12.06 - $14.12 $914,521 - $1.07 Million	75,831	75,831 $1.07 Million

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Innoviva, Inc. Transaction History